BVGH shuffles management, to transfer Global Health Primer

Not-for-profit BIO Ventures for Global Health said Don Joseph will step down as CEO and become chairman. He will succeed Carl Feldbaum, who will remain a director. Jennifer Dent, VP of commercialization and alliance management, will be promoted to president and a director.

BVGH also said it will transfer its Global Health Primer to Emory University's Emory Institute for Drug Development. The Primer is an online resource that tracks drug, vaccines and diagnostic products marketed or in development for 25 neglected tropical diseases. ...